Literature DB >> 16715328

Procalcitonin kinetics in pediatric patients with systemic inflammatory response after open heart surgery.

Serdar Celebi1, Ozge Koner, Ferdi Menda, Huriye Balci, Alican Hatemi, Kubilay Korkut, Figen Esen.   

Abstract

OBJECTIVE: To evaluate procalcitonin and C-reactive protein as markers of inflammation severity and their value in predicting development of organ failure after pediatric open heart surgery.
DESIGN: Prospective, observational, clinical study.
SETTING: Single university hospital. PATIENTS: Thirty-three pediatric patients with systemic inflammatory response syndrome (SIRS; n=19) and SIRS+organ failure (SIRS+OF; n=14) following open heart surgery were included. MEASUREMENTS AND
RESULTS: Plasma procalcitonin and C-reactive protein levels were measured before and after the operation, and 1, 2, 3, and 4 days after surgery. Patients were evaluated daily to assess organ failure. Postoperative procalcitonin levels in the SIRS+OF group were significantly higher than in the SIRS group. C-reactive protein levels were similar between the groups throughout the study period. Peak procalcitonin levels were found to be positively correlated with aortic cross-clamp and cardiopulmonary bypass times, duration of mechanical ventilation, intensive care unit and hospital stay, mortality and organ failure development. Peak procalcitonin was found to be a good predictor of postoperative organ failure development and mortality. However, the predictive value of peak C-reactive protein for organ failure and mortality was found to be weak. Double-peak procalcitonin curves were observed in SIRS+OF patients with infection during the intensive care unit stay.
CONCLUSION: In the SIRS+OF group peak procalcitonin levels were found to be highly predictive for mortality and organ failure development, whereas C-reactive protein levels were not. Daily procalcitonin measurements in SIRS+OF patients may help identify the postoperative infection during the follow-up period.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16715328     DOI: 10.1007/s00134-006-0180-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  36 in total

1.  Effects of cardiac surgery on some clinically used inflammation markers and procalcitonin.

Authors:  C Y Bitkover; L O Hansson; G Valen; J Vaage
Journal:  Scand Cardiovasc J       Date:  2000-06       Impact factor: 1.589

2.  Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass.

Authors:  M Hensel; T Volk; W D Döcke; F Kern; D Tschirna; K Egerer; W Konertz; W J Kox
Journal:  Anesthesiology       Date:  1998-07       Impact factor: 7.892

Review 3.  The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations.

Authors:  R I Hall; M S Smith; G Rocker
Journal:  Anesth Analg       Date:  1997-10       Impact factor: 5.108

4.  High serum procalcitonin level in a 4-year-old liver transplant recipient with a disseminated candidiasis.

Authors:  Y Gérard; D Hober; S Petitjean; M Assicot; C Bohuon; Y Mouton; P Wattré
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

5.  Hyperprocalcitonemia is related to noninfectious postoperative severe systemic inflammatory response syndrome associated with cardiovascular dysfunction after coronary artery bypass graft surgery.

Authors:  F Kerbaul; C Guidon; P J Lejeune; M Mollo; T Mesana; F Gouin
Journal:  J Cardiothorac Vasc Anesth       Date:  2002-02       Impact factor: 2.628

6.  Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: correlation with mortality and postoperative complications.

Authors:  B Adamik; J Kübler-Kielb; B Golebiowska; A Gamian; A Kübler
Journal:  Intensive Care Med       Date:  2000-09       Impact factor: 17.440

7.  Postoperative plasma concentrations of procalcitonin after different types of surgery.

Authors:  M Meisner; K Tschaikowsky; A Hutzler; C Schick; J Schüttler
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440

8.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

9.  Epidemiology of sepsis and multiple organ dysfunction syndrome in children.

Authors:  F Proulx; M Fayon; C A Farrell; J Lacroix; M Gauthier
Journal:  Chest       Date:  1996-04       Impact factor: 9.410

10.  Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS.

Authors: 
Journal:  Crit Care       Date:  1999       Impact factor: 9.097

View more
  9 in total

Review 1.  Utility of Procalcitonin as a Biomarker for Sepsis in Children.

Authors:  Kevin J Downes; Julie C Fitzgerald; Scott L Weiss
Journal:  J Clin Microbiol       Date:  2020-06-24       Impact factor: 5.948

Review 2.  Year in Review in Intensive Care Medicine, 2006. III. Circulation, ethics, cancer, outcome, education, nutrition, and pediatric and neonatal critical care.

Authors:  Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Daniel De Backer; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Duncan Macrae; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerôme Pugin; Michael Pinsky; Peter Radermacher; Christian Richard
Journal:  Intensive Care Med       Date:  2007-02-14       Impact factor: 17.440

3.  Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children.

Authors:  Corsino Rey; Marta Los Arcos; Andrés Concha; Alberto Medina; Soledad Prieto; Pablo Martinez; Belen Prieto
Journal:  Intensive Care Med       Date:  2007-01-27       Impact factor: 17.440

Review 4.  Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature.

Authors:  Christoph Sponholz; Yasser Sakr; Konrad Reinhart; Frank Brunkhorst
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

5.  Markedly elevated procalcitonin in early postoperative period in pediatric open heart surgery: a prospective cohort study.

Authors:  Etsuko Minami; Shoji Ito; Takeshi Sugiura; Yoshihito Fujita; Hiroshi Sasano; Kazuya Sobue
Journal:  J Intensive Care       Date:  2014-06-20

6.  Early Kinetics of Procalcitonin in Predicting Surgical Outcomes in Type A Aortic Dissection Patients.

Authors:  Hua Liu; Zhe Luo; Lan Liu; Xiao-Mei Yang; Ya-Min Zhuang; Ying Zhang; Guo-Wei Tu; Guo-Guang Ma; Guang-Wei Hao; Jian-Feng Luo; Ji-Li Zheng; Chun-Sheng Wang
Journal:  Chin Med J (Engl)       Date:  2017-05-20       Impact factor: 2.628

7.  Acute-phase reactants after paediatric cardiac arrest. Procalcitonin as marker of immediate outcome.

Authors:  Marta Los Arcos; Corsino Rey; Andrés Concha; Alberto Medina; Belen Prieto
Journal:  BMC Pediatr       Date:  2008-04-30       Impact factor: 2.125

8.  Kinetics of procalcitonin and C-reactive protein and the relationship to postoperative infection in young infants undergoing cardiovascular surgery.

Authors:  Jesse Davidson; Suhong Tong; Amanda Hauck; D Scott Lawson; Eduardo da Cruz; Jon Kaufman
Journal:  Pediatr Res       Date:  2013-07-17       Impact factor: 3.756

9.  Procalcitonin as a biomarker of bacterial infection in pediatric patients after congenital heart surgery.

Authors:  Sujata B Chakravarti; Diane A Reformina; Timothy M Lee; Sunil P Malhotra; Ralph S Mosca; Puneet Bhatla
Journal:  Ann Pediatr Cardiol       Date:  2016 May-Aug
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.